We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Clot Treatment Trials Should Be Tailored to Type of Clot: EMA
Clot Treatment Trials Should Be Tailored to Type of Clot: EMA
The European Medicines Agency is revising the way drugmakers conduct studies of drugs to treat blood clots, for the first time separating out the clinical requirements for different types of clots.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor